Description

(±)-1-(4-Fluorophenyl)-4-(3,4,6,7,12,12A-Hexahydropyrazino[1',2':1,6]Pyrido[3,4-B]Indol-2(1H)-Yl)Butan-1-One is a complex heterocyclic organic compound featuring a fused pyrazino-pyridoindole core structure, which is of significant interest in advanced pharmaceutical research and development. This compound matters as a sophisticated chemical intermediate or potential pharmacophore for creating novel therapeutic agents targeting central nervous system disorders. It is primarily needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the synthesis of new chemical entities (NCEs) and active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the research and synthesis of novel psychoactive pharmaceuticals and central nervous system (CNS) agents.
• Medicinal Chemistry Research: Used as a core scaffold or precursor for structure-activity relationship (SAR) studies in drug discovery programs.
• Reference Standard: Serves as a high-purity analytical standard for method development and quality control in API manufacturing.
• Biochemical Research: Potential tool compound for investigating specific biological pathways and receptor interactions in preclinical studies.
• Fine Chemical Synthesis: Intermediate for the custom synthesis of more complex, target-specific molecules for specialized applications.

Basic Information

Product Name	(±)-1-(4-Fluorophenyl)-4-(3,4,6,7,12,12A-Hexahydropyrazino[1',2':1,6]Pyrido[3,4-B]Indol-2(1H)-Yl)Butan-1-One
CAS No.	42021-34-1
Molecular Formula	C25H26FN3O
Molecular Weight	403.50 g/mol
Synonyms	1-(4-Fluorophenyl)-4-(1,3,4,6,7,12-hexahydro-2H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)butan-1-one; 1-(4-Fluorophenyl)-4-(hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-2(1H)-yl)butan-1-one; 42021-34-1; Pyrazino[1',2':1,6]pyrido[3,4-b]indole derivative; UNII-8S3Q8K5Q6F; 8S3Q8K5Q6F; Butan-1-one, 1-(4-fluorophenyl)-4-(1,3,4,6,7,12-hexahydro-2H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-2-yl)-
EINECS	Contact for details

Quality Control

Our (±)-1-(4-Fluorophenyl)-4-(3,4,6,7,12,12A-Hexahydropyrazino[1',2':1,6]Pyrido[3,4-B]Indol-2(1H)-Yl)Butan-1-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting research-grade specifications. Comprehensive Certificates of Analysis (COA) detailing purity, impurities, and analytical methods are provided to support your R&D and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Single Maximum Impurity	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.